Table of Contents

September/October 2024; Volume 78,Issue 5

  1. Lazdins, Alessandro

    1. A Strategic Guide to Improve and De-Risk Vaccine Development: CEPI’s CMC Framework
      Anna Särnefält, Ranna Eardley-Patel, Diletta Magini, Vishal Sonje, Antonio Guzzi, Renske Hesselink, Matthew Scotney, Alessandro Lazdins, Valerie Chambard, Christof Vinnemeier and Ingrid Kromann
      PDA Journal of Pharmaceutical Science and Technology September 2024, 78 (5) 613-623; DOI: https://doi.org/10.5731/pdajpst.2023.012912

  2. Lei, Ming

    1. Identification and Root Cause Analysis of the Visible Particles Commonly Encountered in the Biopharmaceutical Industry
      Bo Wang, Shanshan Zhang, Mengyi Chen, Ming Lei, Tian Gao, Wei Fan, Jincui Huang and Xiaolin Cao
      PDA Journal of Pharmaceutical Science and Technology September 2024, 78 (5) 586-603; DOI: https://doi.org/10.5731/pdajpst.2023.012894

  3. Liu, Weixi

    1. Comparison of Binary Alcohol/Water Solvent Systems to Blood for Extractions of Blood-Contacting Medical Devices
      Mark Anderson Jordi, Taryn Meade, Kevin Rowland, Chih-Hu Ho, Jordan Tocher and Weixi Liu
      PDA Journal of Pharmaceutical Science and Technology September 2024, 78 (5) 560-571; DOI: https://doi.org/10.5731/pdajpst.2023.012892
Back to top

In This Issue